214 related articles for article (PubMed ID: 38593781)
21. A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL).
Johnson S; Dhamne C; Sankaran H; Gandhi KA; Rane P; Moulik NR; Jadhav SM; Gurjar M; Narula G; Banavali S; Gota V
Cancer Chemother Pharmacol; 2022 Dec; 90(6):445-453. PubMed ID: 36251032
[TBL] [Abstract][Full Text] [Related]
22. Inherited GATA3 variant associated with positive minimal residual disease in childhood B-cell acute lymphoblastic leukemia via asparaginase resistance.
Li C; Liang W; He Y; Zhao X; Qian J; Li Z; Jiang C; Zheng Q; Fu X; Zhang W; Liu H; Sun X; Qian M; Zhang H
Clin Transl Med; 2021 Aug; 11(8):e507. PubMed ID: 34459144
[No Abstract] [Full Text] [Related]
23. Distinctive sensitivity of some T-leukemia cell lines to L-asparaginase.
Koishi T; Minowada J; Henderson ES; Ohnuma T
Gan; 1984 Mar; 75(3):275-83. PubMed ID: 6609860
[TBL] [Abstract][Full Text] [Related]
24. Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.
Good Z; Sarno J; Jager A; Samusik N; Aghaeepour N; Simonds EF; White L; Lacayo NJ; Fantl WJ; Fazio G; Gaipa G; Biondi A; Tibshirani R; Bendall SC; Nolan GP; Davis KL
Nat Med; 2018 May; 24(4):474-483. PubMed ID: 29505032
[TBL] [Abstract][Full Text] [Related]
25. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.
Narta UK; Kanwar SS; Azmi W
Crit Rev Oncol Hematol; 2007 Mar; 61(3):208-21. PubMed ID: 17011787
[TBL] [Abstract][Full Text] [Related]
27. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
[TBL] [Abstract][Full Text] [Related]
28. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
29. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
30. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
[TBL] [Abstract][Full Text] [Related]
31. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
[TBL] [Abstract][Full Text] [Related]
32. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Silverman LB; Supko JG; Stevenson KE; Woodward C; Vrooman LM; Neuberg DS; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Laverdière C; Michon B; Schorin M; Schwartz CL; O'Brien JE; Cohen HJ; Sallan SE
Blood; 2010 Feb; 115(7):1351-3. PubMed ID: 20007809
[TBL] [Abstract][Full Text] [Related]
33. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
Amylon MD; Shuster J; Pullen J; Berard C; Link MP; Wharam M; Katz J; Yu A; Laver J; Ravindranath Y; Kurtzberg J; Desai S; Camitta B; Murphy SB
Leukemia; 1999 Mar; 13(3):335-42. PubMed ID: 10086723
[TBL] [Abstract][Full Text] [Related]
34. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
[TBL] [Abstract][Full Text] [Related]
35. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
Figueiredo L; Cole PD; Drachtman RA
Expert Rev Hematol; 2016 Mar; 9(3):227-34. PubMed ID: 26765930
[TBL] [Abstract][Full Text] [Related]
36. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts.
Métayer LE; Brown RD; Carlebur S; Burke GAA; Brown GC
Apoptosis; 2019 Feb; 24(1-2):145-156. PubMed ID: 30578463
[TBL] [Abstract][Full Text] [Related]
38. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
39.
Mootoosamy C; Kondyli M; Serfaty SA; Tremblay DÉ; Gagné V; Ribère M; Laverdière C; Leclerc JM; Sinnett D; Tran TH; Krajinovic M
Pharmacogenomics; 2023 Mar; 24(4):199-206. PubMed ID: 36946317
[TBL] [Abstract][Full Text] [Related]
40. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
Chen SH
Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
